Pradhan Mantri Bhartiya Janaushadhi Pariyojana (PMBJP)

Pradhan Mantri Bhartiya Janaushadhi Pariyojana was launched in 2008 and re launched with substantially expanded scope in 2015. The promise is that quality medicines, sold under their molecule name rather than a brand name, can be dispensed at a fraction of the branded price without compromising on efficacy or safety. The scheme is implemented by the Pharmaceuticals and Medical Devices Bureau of India, an autonomous body under the Department of Pharmaceuticals.

A common worry is that cheap means substandard. The reality is the opposite. Every batch of a Janaushadhi medicine is tested at a NABL accredited laboratory before being released to Kendras. The same molecule sold under a brand at ten times the price uses the same regulatory approvals from the Central Drugs Standard Control Organisation and is manufactured to the same Schedule M standards. The price difference reflects the absence of marketing, distribution margins and sales representative networks, not the chemistry.

For a household managing a chronic condition like hypertension, diabetes or hypothyroidism, the savings are not marginal. A month of branded metformin can cost Rs 200 to Rs 400. The Janaushadhi equivalent is Rs 25 to Rs 40. Over a year, the difference funds a routine diagnostic check or an out of pocket consultation.

The Janaushadhi Sugam app, available on Android and iOS, is the single most useful tool for a patient. Enter your location and it lists nearby Kendras with addresses, distances and operating hours. Search by molecule name and it shows which Kendras have the medicine in stock and at what price. Search by brand name and it suggests the generic equivalent.

If the app shows stock but the Kendra says otherwise, this is usually a sync lag. The app refreshes from the central inventory system every few hours. Phone the Kendra before travelling for a multi medicine purchase. Most Kendra owners will reserve stock for a few hours if you call ahead.

If no Kendra near you stocks the molecule, escalate through the helpline 1800 180 8080. The central team can route stock from a nearby distribution centre, typically within two to four days.

A Kendra is essentially a small retail pharmacy that agrees to stock only PMBJP generics from the central catalogue. Margins on each sale are higher than typical retail pharmacy margins, but volumes depend entirely on location and trust building with prescribing doctors in the neighbourhood.

Eligible applicants include individuals with a pharmacy qualification, NGOs, hospitals, SHGs and cooperatives. The premises must be at least 120 square feet, in a location with reasonable commercial footfall, and within commuting distance of a residential cluster or hospital. A registered pharmacist must be available for the dispensing hours.

For applicants from SC, ST, divyangjan, women and northeast region categories, the central financial assistance can reach Rs 5 lakh. This is split across furniture and fixtures of up to Rs 2 lakh, computers and printers of up to Rs 50,000 and a monthly handholding allowance for the first six months. For general category applicants, the incentive is a 20 percent margin on monthly sales subject to a Rs 20,000 monthly ceiling for the first 12 months.

The application is online at janaushadhi.gov.in. After document verification, a site inspection follows. If approved, a unique Kendra code is issued and the first stock allocation is dispatched against an advance security amount.

Amlodipine 5 mg, used for hypertension, has a branded MRP of around Rs 80 to Rs 110 for 10 tablets depending on brand. The Janaushadhi price is Rs 11 to Rs 14 for the same strip. A patient on lifelong therapy saves about Rs 1,000 a year on this single medicine.

Metformin 500 mg, used for type 2 diabetes, has a branded MRP of around Rs 30 to Rs 80 for 10 tablets. The Janaushadhi price is Rs 5 to Rs 8. For a patient on twice daily dosing, annual savings are Rs 1,500 to Rs 3,000.

Atorvastatin 10 mg, used for cholesterol, has a branded MRP of around Rs 70 to Rs 200 for 10 tablets. The Janaushadhi price is Rs 12 to Rs 20. A patient also on a statin, blood pressure and diabetes regimen typically saves Rs 6,000 to Rs 10,000 a year by switching to Janaushadhi for all three.

Doctors sometimes prescribe by brand name and resist a generic substitution. This is legal but you can ask for the molecule to be written in the prescription. Most Kendras can dispense the generic equivalent against a brand prescription if the molecule and strength are unambiguous.

Insurance reimbursement claims sometimes ask for a brand printed bill. The Janaushadhi Kendra bill clearly lists the molecule, strength, batch number and manufacturer. Most insurance companies accept this. If yours does not, ask for a written denial and escalate through IRDAI.

If a Janaushadhi medicine appears different in colour or shape from the branded version you were taking, this is expected. Generic manufacturers use different excipients. The active ingredient and dose are identical. If you notice a clinical change, report it to your doctor and to the PMBJP helpline so the batch can be reviewed.

• 01Buyers: any individual with a valid prescription. No income or category restriction
• 02Kendra owners: individuals, NGOs, charitable organisations, hospitals, pharmacy degree holders, SHGs and cooperatives
• 03Kendra owner must have a minimum 120 square feet space in a commercial area with good footfall
• 04For incentive eligible categories, valid SC, ST, divyangjan or northeast domicile certificate is required
• 05Pharmacist registration with the State Pharmacy Council is mandatory for the dispensing staff

• §For buyers: a valid prescription from a registered medical practitioner
• §For Kendra owners: Aadhaar, PAN, photograph, bank account details
• §Pharmacy council registration certificate of the proposed pharmacist
• §Proof of premises ownership or rent agreement and trade licence
• §Category certificate for SC, ST, women, divyangjan or northeast applicants seeking enhanced incentives
• §GST registration where applicable

• Kendra application without a registered pharmacist
• Premises smaller than the minimum 120 square feet
• Location in close proximity to an existing operational Janaushadhi Kendra
• Incomplete or unverifiable category certificates for incentive claims
• Failure to deposit the security amount within the prescribed timeline after provisional allotment

• Pradhan Mantri Bhartiya Janaushadhi Pariyojana official portal, Pharmaceuticals and Medical Devices Bureau of Indialink ↗
• PMBJP guidelines and product catalogue, Department of Pharmaceuticals, Ministry of Chemicals and Fertilizerslink ↗